Figure 19
T
T
T
oT
T
7
T
4
4
40
4
»
gi) za
‘a
TTF
tT
- (B)
‘tr
¥
T
—
Lo
F
T
T
T
T
4
4
4
10
1a
32
4
5
#20
4
a f
.
~s
4
a
4
4
2
PLAT
60
4
>»
z
%
4
4
2.
Qo
|
61OOUlU1300C(6200
250)
|
«6300
200
250
3100
350
|
400
4
7
6
4
4
4
4
“{
2
4
ottttit tt |
q
aso
30.
|
a
7
0
4
moe i cd lg
7O
a0
ao oo
«63800400
1
1
4
°
o50
1o
Oot
FE te)
1.06
1§0
200
250
306
i
ee
aa
356
ee
+ (F)
4
”
ar
-
ar
is
.
4
2 6k
“4
= “T
>
4
a
w
t
o
O
ot
VO
O02
b (G)
O04
oo
O68
i
O8
Ln
10
#t2
[TTT]
14
i
#16
#%18
TTT Tt
~
zz 6
5
ry
Fk
1
:
a
|
t cL
20
o®
o80
OTT
iW)
~
€F
4
be
#100
#150
[
200
bn
290
dl,
300
J
350
Tt
4
=
7
4
_
=
J
{+
~
2-
“4
—
=
=
ze
rn
=
%
-
“rT
4of.
i
of
g
4
+
CC
4
oe
«4
-
;
1
w 4
6r
f
|
iL
050 100 180 2.00 250 300 330 400 450
DOSE EQUIVALENT, Rem
;o
10
20 30
40
50
(F) Adolescente
on Rongelap,
(E) Young Adults
(G) Children and (H) Infance
40
oon
FO @0 90
OOSE EQUIVALENT, Rem
Fig. 19 1374, Dose Equivalent to (A} All
Residents
{B) Adults
(C)
Adult Males
(D) Adult Femalea
60
=~